All News

Is patient desperation enough? Philosophy Professor and IPPP Fellow Andrew Peterson assesses the FDA's controversial decision to approve a new Alzheimer's drug

Is patient desperation enough? Philosophy Professor and IPPP Fellow Andrew Peterson assesses the FDA's controversial decision to approve a new Alzheimer's drug

"If the standard for drug approval moving forward is simply going to be 'whatever patients are willing to try,' then we don’t need the FDA at all." Andrew Peterson and colleagues from the University of Pennsylvania, Holly Lynch and Emily Largent, assess the FDA's recent controversial decision in this op-ed first published in USA Today.

Read More